Fichero a descargar de la publicaciÃ³n mostrada - Sociedad ...

More documents

Recommendations

Info

Octubre 2011 INFECCIONES RELACIONADAS CON CATÉTERES VASCULARES Pág. 50______________________________________________________________________________147. Krause DS, Simjee AE, van RC, et al. A randomized, double-blind trial of anidulafungin versus fluconazolefor the treatment of esophageal candidiasis. Clin Infect Dis 2004; 39:770-5.148. Kuse ER, Chetchotisakd P, da Cunha CA, et al. Micafungin versus liposomal amphotericin B for candidaemiaand invasive candidosis: a phase III randomised double-blind trial. Lancet 2007; 369:1519-27.149. Pappas PG, Rotstein CM, Betts RF, et al. Micafungin versus caspofungin for treatment of candidemia andother forms of invasive candidiasis. Clin Infect Dis 2007; 45:883-93.150. Kullberg BJ, Sobel JD, Ruhnke M, et al. Voriconazole versus a regimen of amphotericin B followed byfluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial. Lancet 2005;366:1435-42.151. Walsh TJ. Echinocandins-an advance in the primary treatment of invasive candidiasis. N Engl J Med 2002;347:2070-2.152. Espinel-Ingroff A, Barchiesi F, Cuenca-Estrella M, et al. International and multicenter comparison ofEUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. tofluconazole, itraconazole, posaconazole, and voriconazole. J Clin Microbiol 2005; 43:3884-9.153. Rex JH, Bennett JE, Sugar AM, et al. Intravascular catheter exchange and duration of candidemia. NIAIDMycoses Study Group and the Candidemia Study Group. Clin Infect Dis 1995; 21:994-6.154. Nguyen MH, Peacock JE Jr., Tanner DC, et al. Therapeutic approaches in patients with candidemia.Evaluation in a multicenter, prospective, observational study. Arch Intern Med 1995; 155:2429-35.155. Luzzati R, Amalfitano G, Lazzarini L, et al. Nosocomial candidemia in non-neutropenic patients at an Italiantertiary care hospital. Eur J Clin Microbiol Infect Dis 2000; 19:602-7.156. Liu CY, Huang LJ, Wang WS, et al. Candidemia in cancer patients: impact of early removal of non-tunneledcentral venous catheters on outcome. J Infect 2009; 58:154-60.157. Rodríguez D, Park BJ, Almirante B, et al. Impact of early central venous catheter removal on outcome inpatients with candidaemia. Clin Microbiol Infect 2007; 13:788-93.158. Luzzati R, Allegranzi B, Pecorari E, Concia E. Central venous catheter removal from patients withcandidaemia. Clin Microbiol Infect 2008; 14:516-7.159. Koh GC, Luong ML. Early removal of central venous catheters and outcomes from candidemia. Clin InfectDis 2010; 51:1347-50.160. Bouza E, Burillo A, Muñoz P. Empiric therapy for intravenous central line infections and nosocomiallyacquiredacute bacterial endocarditis. Crit Care Clin 2008; 24:293-2ix.161. Jacoby GA, Muñoz-Price LS. The new beta-lactamases. N Engl J Med 2005; 352:380-91.162. Raymond DP, Pelletier SJ, Crabtree TD, Evans HL, Pruett TL, Sawyer RG. Impact of antibiotic-resistantGram-negative bacilli infections on outcome in hospitalized patients. Crit Care Med 2003; 31:1035-41.163. Paterson DL, Ko WC, Von GA, et al. Outcome of cephalosporin treatment for serious infections due toapparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinicalmicrobiology laboratory. J Clin Microbiol 2001; 39:2206-12.164. Lorente L, Jiménez A, Santana M, et al. Microorganisms responsible for intravascular catheter-relatedbloodstream infection according to the catheter site. Crit Care Med 2007; 35:2424-7.165. Muñoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med 2008; 358:1271-81.166. Friedman ND, Korman TM, Fairley CK, Franklin JC, Spelman DW. Bacteraemia due to Stenotrophomonasmaltophilia: an analysis of 45 episodes. J Infect 2002; 45:47-53.
Octubre 2011 INFECCIONES RELACIONADAS CON CATÉTERES VASCULARES Pág. 51______________________________________________________________________________167. Micek ST, Welch EC, Khan J, et al. Empiric combination antibiotic therapy is associated with improvedoutcome against sepsis due to Gram-negative bacteria: a retrospective analysis. Antimicrob Agents Chemother2010; 54:1742-8.168. Fowler VG Jr., Justice A, Moore C, et al. Risk factors for hematogenous complications of intravascularcatheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis 2005; 40:695-703.169. Jensen AG, Espersen F, Skinhoj P, Rosdahl VT, Frimodt-Moller N. Increasing frequency of vertebralosteomyelitis following Staphylococcus aureus bacteraemia in Denmark 1980-1990. J Infect 1997; 34:113-8.170. Jensen AG, Espersen F, Skinhoj P, Frimodt-Moller N. Bacteremic Staphylococcus aureus spondylitis. ArchIntern Med 1998; 158:509-17.171. Khan EA, Correa AG, Baker CJ. Suppurative thrombophlebitis in children: a ten-year experience. PediatrInfect Dis J 1997; 16:63-7.172. Maki DG, McCormick RD, Uman SJ, Wirtanen GW. Septic endarteritis due to intra-arterial catheters forcancer chemotherapy. I. Evaluation of an outbreak. II. Risk factors, clinical features and management, III.Guidelines for prevention. Cancer 1979; 44:1228-40.173. Andes DR, Urban AW, Acher CW, Maki DG. Septic thrombosis of the basilic, axillary, and subclavian veinscaused by a peripherally inserted central venous catheter. Am J Med 1998; 105:446-50.174. Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters incancer patients. J Clin Oncol 2003; 21:3665-75.175. Crowley AL, Peterson GE, Benjamin DK Jr., et al. Venous thrombosis in patients with short- and long-termcentral venous catheter-associated Staphylococcus aureus bacteremia. Crit Care Med 2008; 36:385-90.176. Johnson RA, Zajac RA, Evans ME. Suppurative thrombophlebitis: correlation between pathogen andunderlying disease. Infect Control 1986; 7:582-5.177. Fowler VG Jr., Scheld WM, Bayer AS. Endocarditis and intravascular infections. In: Mandell GL, Bennett JE,Dolin R, editors. Mandell, Douglas and Bennett's. Principles and Practice of Infectious Diseases. 7th ed.Philadelphia: Churchill Livingstone; 2010 p. 1067-112.178. Ghanem GA, Boktour M, Warneke C, et al. Catheter-related Staphylococcus aureus bacteremia in cancerpatients: high rate of complications with therapeutic implications. Medicine (Baltimore) 2007; 86:54-60.179. Timsit JF, Farkas JC, Boyer JM, et al. Central vein catheter-related thrombosis in intensive care patients:incidence, risks factors, and relationship with catheter-related sepsis. Chest 1998; 114:207-13.180. Stein JM, Pruitt BA Jr. Suppurative thrombophlebitis. A lethal iatrogenic disease. N Engl J Med 1970;282:1452-5.181. Munster AM. Septic thrombophlebitis. A surgical disorder. JAMA 1974; 230:1010-1.182. Pruitt BA Jr., McManus WF, Kim SH, Treat RC. Diagnosis and treatment of cannula-related intravenoussepsis in burn patients. Ann Surg 1980; 191:546-54.183. Strinden WD, Helgerson RB, Maki DG. Candida septic thrombosis of the great central veins associated withcentral catheters. Clinical features and management. Ann Surg 1985; 202:653-8.184. Kaufman J, Demas C, Stark K, Flancbaum L. Catheter-related septic central venous thrombosis-currenttherapeutic options. West J Med 1986; 145:200-3.185. van Rooden CJ, Schippers EF, Barge RM, et al. Infectious complications of central venous catheters increasethe risk of catheter-related thrombosis in hematology patients: a prospective study. J Clin Oncol 2005; 23:2655-60.
Page 1 and 2: AVANCES ENENFERMEDADES INFECCIOSASP
Page 3 and 4: Octubre 2011 INFECCIONES RELACIONAD
Page 49: Octubre 2011 INFECCIONES RELACIONAD

Fichero a descargar de la publicaciÃ³n mostrada - Sociedad ...

Create successful ePaper yourself

Delete template?

Save as template?